A case of hysteroscopic resection of retained products of conception, metroplasty, and adhesiolysis
Introduction (Video 1)
One 23-year-old woman underwent her first-time induced abortion 50 days before because of missed abortion, complaint that no menstruation appears. She has an irregular menstrual cycle from 30 to 180 days and had been diagnosed with polycystic ovary syndrome (PCOS) for 3 months. 3D ultrasound results revealed that her uterus presented partial septum (depth from the interstitial line to the apex of the indentation 1.4 cm), and there was a 16 mm × 7 mm local retained product of conception in her right uterus. Her serum beta human chorionic gonadotropin (β-HCG) was 8.02 IU/L (reference value: 0–5 IU/L for no pregnant). After pretreatment with mifepristone and estrogen for 6 days, her serum β-HCG dropped to 5.77 IU/L. So her preoperative diagnoses were: (I) retained products of conception; (II) partial uterine septum. During the operation, we found she combined with adhesion at the same time. In the same patient, one or two diseases are common, but it is rare to have three diseases at the same time, and it is more difficult to treat various diseases successfully at the same time. So we completely removed the retained products of conception and performed metroplasty, adhesiolysis successfully in one hysteroscopic process. Finally, she was diagnosed with: (I) retained products of conception; (II) partial uterine septum; (III) uterine adhesion. Three months after surgery, diagnostic hysteroscopy findings indicated that her uterine cavity was normal, both tubal ostiums were visible.
We present the following article in accordance with the CARE reporting checklist (available at https://gpm.amegroups.org/article/view/10.21037/gpm-20-71/rc).
Operative techniques
The patient was routinely given a laryngeal mask anesthesia and lithotomy position, bipolar hysteroscopy was used for resection, with 2D ultrasound supervising the entire operation process. Saline was used as a distension medium with dilatation pressure of 100–120 mmHg. Before the hysteroscopic resection, the entire uterine cavity has been carefully inspected, uterine cavity morphology, bilateral tubal ostiums, and endometrial thickness were also be carefully evaluated (Figure 1). For this patient, moderate IUA has been diagnosed except septum and retained products. So our hysteroscopic procedures were as follows: (I) retained products were directly visualized and precisely removed, a bipolar electronic loop was used as a cold loop to clear retained products to protect the surrounding normal endometrium (Figure 2). (II) A bipolar needle was used for uterine septum incision, and transabdominal ultrasound has been used concurrently to confirm uterine contour and assesses complete removal of the septum (Figure 3) (1). In the operation of hysteroscopic adhesiolysis, bipolar electric needle resects bilateral wall adhesions by horizon with ipsilateral tubal ostium, until the uterine cavity was restored and bilateral tubal ostiums can be observed (Figure 4).
All procedures performed in studies involving human participants were in accordance with the Helsinki Declaration (as revised in 2013). Informed consent was obtained from the patient for publication of this manuscript and any accompanying images.
Comments
Septate uterus has been reported that it will increase the risk of miscarriage, or poor obstetrical outcomes (e.g., premature delivery, or malpresentation) (2). Hysteroscopic resection of the septet uterus is standardly being performed in women of reproductive age and wish to conceive (3). For this patient, uterine septum caused her missed abortion and increased the risk of pregnancy residue, nonvisual curettage laded to uterine adhesion. So it is necessary for her to use hysteroscopic procedures to resolve all these problems. Though there are various options to choose: cold scissors, unipolar, bipolar cautery, or laser (1). There still is insufficient evidence to recommend one over the other. During the surgery, the “cold loop” technique was applied to bipolar resectoscope to decrease the chance of post-surgical adhesion. According to the American Association of Gynecologic Laparoscopists (AAGL)/European Society of Gynaecological Endoscopy (ESGE) guideline, we used an intrauterine device (IUD) and sequential estrogen and progestin three cycles to prevent re-adhesion (4).
Acknowledgments
The video was awarded the second prize in the Second International Elite Gynecologic Surgery Competition (2020 Masters of Gynecologic Surgery).
Funding: None.
Footnote
Provenance and Peer Review: This article was commissioned by the editorial office, Gynecology and Pelvic Medicine for the series “Award-Winning Videos from the Second International Elite Gynecologic Surgery Competition (2020 Masters of Gynecologic Surgery)”. The article has undergone external peer review.
Reporting Checklist: The author has completed the CARE reporting checklist. Available at https://gpm.amegroups.org/article/view/10.21037/gpm-20-71/rc
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://gpm.amegroups.org/article/view/10.21037/gpm-20-71/coif). The series “Award-Winning Videos from the Second International Elite Gynecologic Surgery Competition (2020 Masters of Gynecologic Surgery)” was commissioned by the editorial office without any funding or sponsorship. The author has no other conflicts of interest to declare.
Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in studies involving human participants were in accordance with the Helsinki Declaration (as revised in 2013). Informed consent was obtained from the patient for publication of this manuscript and any accompanying images.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Di Spiezio Sardo A, Calagna G, Scognamiglio M, et al. Prevention of intrauterine post-surgical adhesions in hysteroscopy. A systematic review. Eur J Obstet Gynecol Reprod Biol 2016;203:182-92. [Crossref] [PubMed]
- Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril 2016;106:530-40.
- Rikken JFW, Kowalik CR, Emanuel MH, et al. The randomised uterine septum transsection trial (TRUST): design and protocol. BMC Womens Health 2018;18:163. [Crossref] [PubMed]
- Elevating AAGL. Gynecologic Surgery. AAGL Practice Report: Practice Guidelines on Intrauterine Adhesions Developed in Collaboration With the European Society of Gynaecological Endoscopy (ESGE). J Minim Invasive Gynecol 2017;24:695-705. [Crossref] [PubMed]
Cite this article as: Li C. A case of hysteroscopic resection of retained products of conception, metroplasty, and adhesiolysis. Gynecol Pelvic Med 2021;4:13.